Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts.
G T Gamblin, … , D A DeGrange, S J Marx
G T Gamblin, … , D A DeGrange, S J Marx
Published March 1, 1985
Citation Information: J Clin Invest. 1985;75(3):954-960. https://doi.org/10.1172/JCI111796.
View: Text | PDF
Research Article

Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts.

  • Text
  • PDF
Abstract

1,25(OH)2D3 induces 25(OH)D3-24-hydroxylase (24-OHase) in cultured skin fibroblasts from normal subjects. We evaluated 24-OHase induction by 1,25(OH)2D3 in skin fibroblasts from 10 normal subjects and from four unrelated patients with hereditary resistance to 1,25(OH)2D or vitamin D-dependent rickets type II (DD II). Fibroblasts were preincubated with varying concentrations of 1,25(OH)2D3 for 15 h and were then incubated with 0.5 microM [3H]25(OH)D3 at 37 degrees C for 30 min; lipid extracts of the cells were analyzed for [3H]24,25(OH)2D3 by high performance liquid chromatography and periodate oxidation. Apparent maximal [3H]24,25(OH)2D3 production in normal cell lines was 9 pmol/10(6) cells per 30 min and occurred after induction with 10(-8) M 1,25(OH)2D3. 24-OHase induction was detectable in normal fibroblasts at approximately 3 X 10(-10) M 1,25(OH)2D3. [3H]24,25(OH)2D3 formation after exposure to 1,25(OH)2D3 was abnormal in fibroblasts from all four patients with DD II. In fibroblasts from two patients with DD II, [3H]24,25(OH)2D3 formation was unmeasurable (below 0.2 pmol/10(6) cells per 30 min) at 1,25(OH)2D3 concentrations up to 10(-6) M. Fibroblasts from the other two patients with DD II required far higher than normal concentrations of 1,25(OH)2D3 for detectable [3H]24,25(OH)2D3 induction. In one, [3H]24,25(OH)2D3 production reached 2.9 pmol/10(6) cells per 30 min at 10(-6) M 1,25(OH)2D3 (30% normal maximum at 10(-6) M 1,25(OH)2D3). In the other, [3H]24,25(OH)2D3 production achieved normal levels, 7.3 pmol/10(6) cells per 30 min after 10(-6) M 1,25(OH)2D3. The two patients whose cells had a detectable 24-OHase induction by 1,25(OH)2D3 showed a calcemic response to high doses of calciferols in vivo. Our current observations correlate with these two patients' responsiveness to calciferols in vivo and suggest that their target organ defects can be partially or completely overcome with extremely high concentrations of 1,25(OH)2D3. The two patients whose cells showed no detectable 24-OHase induction in vitro failed to show a calcemic response to high doses of calciferols in vivo. In conclusion: (a) the measurement of 24-OHase induction by 1,25(OH)2D3 in cultured skin fibroblasts is a sensitive in vitro test for defective genes in the 1,25(OH)2D effector pathway. (b) This assay provides a useful tool for characterizing the target tissue defects in DD II and predicting response to calciferol therapy.

Authors

G T Gamblin, U A Liberman, C Eil, R W Downs Jr, D A DeGrange, S J Marx

×

Total citations by year

Year: 2013 2012 2011 2008 2006 2003 2000 1999 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1981 Total
Citations: 1 2 1 1 1 1 1 2 3 1 5 2 3 3 6 4 5 7 3 2 1 55
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (55)

Title and authors Publication Year
Emery and Rimoin's Principles and Practice of Medical Genetics
DC Wallace, MT Lott, V Procaccio
Emery and Rimoin's Principles and Practice of Medical Genetics 2013
Rickets Due to Hereditary Abnormalities of Vitamin D Synthesis or Action
AA Portale, F Perwad, WL Miller
Pediatric Bone 2012
Pediatric Bone
M Bastepe, H Jüppner, RV Thakker
Pediatric Bone 2012
Hereditary 1,25-Dihydroxyvitamin-D-Resistant Rickets
PJ Malloy, D Tiosano, D Feldman
Vitamin D 2011
Principles of Bone Biology
CJ Rosen, T Niu
Principles of Bone Biology 2008
Vitamin D resistance
R Bouillon, A Verstuyf, C Mathieu, SV Cromphaut, R Masuyama, P Dehaes, G Carmeliet
Best Practice & Research Clinical Endocrinology & Metabolism 2006
Vitamin D-dependent rickets Type II with alopecia: two case reports and review of the literature
S Al-Khenaizan, P Vitale
International Journal of Dermatology 2003
The Genetics of Osteoporosis and Metabolic Bone Disease
MJ Econs
2000
Hormone Resistance Syndromes
JL Jameson
1999
The Vitamin D Receptor and the Syndrome of Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets*
PJ Malloy, JW Pike, D Feldman
Endocrine reviews 1999
Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness
PJ Malloy, TR Eccleshall, C Gross, LV Maldergem, R Bouillon, D Feldman
Journal of Clinical Investigation 1997
Vitamin D-dependent rickets type I and type II
E Takeda, H Yamamoto, Y Taketani, KI Miyamoto
Pediatrics International 1997
Advances in Molecular and Cell Biology
KJ Clemetson
Advances in Molecular and Cell Biology 1997
Vitamin D receptor expression is required for growth modulation by 1α,25-dihydroxyvitamin D3 in the human prostatic carcinoma cell line ALVA-31
TE Hedlund, KA Moffatt, GJ Miller
The Journal of Steroid Biochemistry and Molecular Biology 1996
Vitamin D dependent rickets type II and normal vitamin D receptor cDNA sequence. A cluster in a rural area of Cauca, Colombia, with more than 200 affected children
A Giraldo, W Pino, LF García-Ramírez, M Pineda, A Iglesias
Clinical Genetics 1995
Calcitriol-resistant rickets due to vitamin D receptor defects
Z Hochberg, Y Weisman
Trends in Endocrinology & Metabolism 1995
Calcium transport in epithelial cells of the intestine and kidney
R Kumar
Journal of Cellular Biochemistry 1995
Vitamin D deficiency in veterans with chronic spinal cord injury
WA Bauman, YG Zhong, E Schwartz
Metabolism 1995
Advances in Drug Research
CL Crespi
Advances in Drug Research 1995
Two mutations causing vitamin D resistant rickets: modelling on the basis of steroid hormone receptor DNA-binding domain crystal structures
AR Rut, Y Hewlson, K Kristjansson, B Luisl, MR Hughes, JL O'Riordan
Clinical Endocrinology 1994
4 Vitamin D resistance
M Hewison, JL O'Riordan
Baillière's Clinical Endocrinology and Metabolism 1994
Effect of substituting fluorine for hydrogen at C-26 and C-27 on the side chain of 1,25-dihydroxyvitamin D3
M Inaba, S Okuno, Y Nishizawa, Y Imanishi, T Katsumata, I Sugata, H Morii
Biochemical Pharmacology 1993
Biochemistry of Zinc
AS Prasad
1993
The adenovirus-mediated delivery of a reporter gene permits the assessment of androgen receptor function in genital skin fibroblast cultures. Stimulation of Gs and inhibition of G(o)
MJ McPhaul, JP Deslypere, DR Allman, RD Gerard
The Journal of biological chemistry 1993
Characterization and regulation of the vitamin D hydroxylases
HJ Armbrecht, K Okuda, N Wongsurawat, RK Nemani, ML Chen, MA Boltz
The Journal of Steroid Biochemistry and Molecular Biology 1992
Calcium therapy for calcitriol-resistant rickets
Z Hochberg, D Tiosano, L Even
The Journal of Pediatrics 1992
Differential metabolism of 25-hydroxyvitamin D3 by cultured synovial fluid macrophages and fibroblast-like cells from patients with arthritis
ME Hayes, D Bayley, P Still, J Palit, J Denton, AJ Freemont, RG Cooper, EB Mawer
Annals of the rheumatic diseases 1992
Clinical and biochemical findings in parents of children with vitamin D-dependent rickets type II
I Yokota, E Takeda, M Ito, H Kobashi, T Saijo, Y Kuroda
Journal of Inherited Metabolic Disease 1991
Vitamin D dependent rickets type II with myelofibrosis and immune dysfunction
MM Walka, S Däumling, HB Hadorn, K Kruse, BH Belohradsky
European Journal of Pediatrics 1991
Genetic Defects of the 1,25-Dihydroxyvitamin D3Receptor
MR Hughes, PJ Malloy, BW O'malley, JW Pike, D Feldman
Journal of Receptors and Signal Transduction 1991
(21) Type 2 vitamin D-dependent rickets with alopecia
M Sheehan, M Dillon, D Atherton
British Journal of Dermatology 1991
Characteristics of the 25-hydroxyvitamin D3- and 1,25-dihydroxyvitamin D3-24-hydroxylase(s) from HL-60 cells
M Inaba, M Burgos-Trinidad, HF DeLuca
Archives of Biochemistry and Biophysics 1991
Vitamin D dependent rickets type II with myelofibrosis and immune dysfunction
MM Walka, S Däumling, , K Kruse, BH Belohradsky
European Journal of Pediatrics 1991
The molecular basis of hereditary 1,25-dihydroxyvitamin D3 resistant rickets in seven related families
PJ Malloy, Z Hochberg, D Tiosano, JW Pike, MR Hughes, D Feldman
Journal of Clinical Investigation 1990
Hereditary 1,25-dihydroxyvitamin D resistant rickets: Molecular basis and implications for the role of 1,25(OH)2D3 in normal physiology
D Feldman, PJ Malloy
Molecular and Cellular Endocrinology 1990
Lymphocyte cell lines from vitamin D-dependent rickets type II show functional defects in the 1 alpha,25-dihydroxyvitamin D3 receptor
D D'Ambrosio, M Cippitelli, MG Cocciolo, D Mazzeo, PD Lucia, R Lang, F Sinigaglia, P Panina-Bordignon
Molecular and Cellular Endocrinology 1990
Lymphocyte cell lines from vitamin D-dependent rickets type II show functional defects in the 1α,25-dihydroxyvitamin D3 receptor
HP Koeffler, JE Bishop, H Reichel, F Singer, A Nagler, A Tobler, M Walka, AW Norman
Molecular and Cellular Endocrinology 1990
Selective expression of a normal action of the 1,25-dihydroxyvitamin D3 receptor in human skin fibroblasts with hereditary severe defects in multiple actions of that receptor
J Barsony, W McKoy, DA DeGrange, UA Liberman, SJ Marx
Journal of Clinical Investigation 1989
Two siblings with vitamin-D-dependent rickets type II: No recurrence of rickets for 14 years after cessation of therapy
E Takeda, I Yokota, I Kawakami, T Hashimoto, Y Kuroda, S Arase
European Journal of Pediatrics 1989
An ochre mutation in the vitamin D receptor gene causes hereditary 1,25-dihydroxyvitamin D3-resistant rickets in three families
HH Ritchie, MR Hughes, ET Thompson, PJ Malloy, Z Hochberg, D Feldman, JW Pike, BW O'Malley
Proceedings of the National Academy of Sciences 1989
Southwestern Internal Medicine Conference: Clinical Disorders of Renal Tubular Phosphate Transport
M Levi
The American Journal of the Medical Sciences 1989
Mutant vitamin D receptors which confer hereditary resistance to 1,25-dihydroxyvitamin D3 in humans are transcriptionally inactive in vitro
T Sone, RA Scott, MR Hughes, PJ Malloy, D Feldman, BW O'Malley, JW Pike
The Journal of biological chemistry 1989
Vitamin D
A Portale, Β Halloran, E Lonergan, R Morris
Vitamin D 1988
Tissue-selective 1,25-dihydroxyvitamin D3 resistance: Novel applications of calciferols
SJ Marx, J Barsony
Journal of Bone and Mineral Research 1988
Human Melanoma Cells: Functional Modulation by Calciotropic Hormones
RS Mason, AM Pryke, M Ranson, HE Thomas, S Posen
Journal of Investigative Dermatology 1988
Vitamin D and parotid gland function in the rat
C Peterfy, A Tenenhouse, E Yu
The Journal of Physiology 1988
Receptor-mediated rapid action of 1 alpha,25-dihydroxycholecalciferol: increase of intracellular cGMP in human skin fibroblasts
J Barsony, SJ Marx
Proceedings of the National Academy of Sciences 1988
6 Osteomalacia
JA Eisman
Baillière's Clinical Endocrinology and Metabolism 1988
Point mutations in the Human Vitamin D Receptor Gene Associated with Hypocalcemic Rickets
MR Hughes, PJ Malloy, DG Kieback, RA Kesterson, JW Pike, D Feldman, BW O'Malley
Science 1988
Endocrine control and disturbances of calcium and phosphate metabolism in children
K Kruse
European Journal of Pediatrics 1987
Regulation of 24-hydroxylase activity in mouse skin fibroblasts by cholecalciferol derivatives, triamcinolone acetonide and a calcium modulating agent, nicardipine
L Cancela, C Rebut-Bonneton
Journal of Steroid Biochemistry 1987
Hormone Resistance and Other Endocrine Paradoxes
MP Cohen, PP Foà
1987
ANALYSIS OF THE RELATION BETWEEN ALOPECIA AND RESISTANCE TO 1,25-DIHYDROXYVITAMIN D
SJ Marx, MM Bliziotes, M Nanes
Clinical Endocrinology 1986
Steroid Hormone Resistance
GP Chrousos, DL Loriaux, MB Lipsett
1986
Contemporary Nephrology
S Klahr, SG Massry
1981

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts